التفاصيل البيبلوغرافية
| العنوان: |
1230PD - Phase 1B Study of Oral Dual-Pi3K/Mtor Inhibitor Gdc-0980 in Combination with Carboplatin (Carbo)/Paclitaxel (Pac) ± Bevacizumab (Bev) and Cisplatin (Cis)/Pemetrexed (Pem) in Patients (Pts) with Advanced Solid Tumors and Nsclc |
| المؤلفون: |
Calvo, E., Boni, V., Heist, R.S., Matulonis, U., Janne, P.A., Hamid, O., Holgado, E., Ordoñez, J.M., Nunez, J., Ugrenovic, M., Lin, W., O'keeffe, B., Lackner, M.R., Spoerke, J., Ware, J., Pinder-Schenck, M. |
| المصدر: |
In Annals of Oncology September 2014 25 Supplement 4:iv429-iv429 |
| قاعدة البيانات: |
ScienceDirect |
